Mesothelioma Clinical Trials Overview > Mesothelioma Clinical Trial List
Study Using Chemotherapy +/- Pleurectomy/Decortication Followed By Intensity Modulated Radiation Therapy
| Conditions: | Mesothelioma |
| Start Date: | July 1, 2008 |
| Phase: | Phase II |
| Status: | Recruiting |
| NCT ID: | NCT00715611 |
| Study Type: | Interventional |
| Intervention: | Other: Pemetrexed + Cisplatin or Carboplatin AUC=5 Pleurectomy/decortication (if feasible) Intensity Modulated Radiation Therapy |
| Study Design: | Endpoint Classification: Safety/Efficacy Study|Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment |
| Results: | No Results Available |
| Sponsors: | Memorial Sloan-Kettering Cancer Center|Eli Lilly and Company |
| Ages: | Adult|Senior |
| Enrollment: | 28 |
| Funded By: | Other|Industry |
| First Received: | July 11, 2008 |
| End Date: | July 1, 2011 |
| Last Updated: | December 6, 2010 |
| Last Verified: | December 1, 2010 |
Mesothelioma
Lawsuit Evaluation
Lawsuit Evaluation
